Liver Fellow Network (@liverfellow) 's Twitter Profile
Liver Fellow Network

@liverfellow

Collaborative online learning for trainees interested in hepatology | Founded by @hershshroff @LizzieAbyMD @paritapatelmd @adam_c_winters @alexsvogel | #MedEd

ID: 1255674377653440517

linkhttp://liverfellow.org calendar_today30-04-2020 01:44:45

1,1K Tweet

9,9K Followers

266 Following

Hanna Blaney, MD, MPH (@blaneymd) 's Twitter Profile Photo

Thrilled to share that I was awarded the 2024 Ashwani K. Singal Advanced/Transplant Hepatology Fellow Award for Research in Alcohol-Associated Liver Disease. Special thanks to my mentors, AASLD Foundation, & Ashwani Singal for supporting my goal of becoming an ALD investigator!

Thrilled to share that I was awarded the 2024 Ashwani K. Singal Advanced/Transplant Hepatology Fellow Award for Research in Alcohol-Associated Liver Disease.

Special thanks to my mentors, <a href="/AASLDFoundation/">AASLD Foundation</a>, &amp; <a href="/singal_ashwani/">Ashwani Singal</a> for supporting my goal of becoming an ALD investigator!
Liver Fellow Network (@liverfellow) 's Twitter Profile Photo

For all #GITwitter fellows starting today 🤪 We know how stressful but yet enjoyable the first weeks will be 🤩 Liver Fellow Network got you 👌🏻 we have prepared a list if tips and tricks that will make you ✨ ✅ aasld.org/liver-fellow-n… ✅ aasld.org/liver-fellow-n… #GITwitter #MedEd

Liver Fellow Network (@liverfellow) 's Twitter Profile Photo

Resmetirom (thyroid hormone receptor beta-selective agonist) has made 🌊 waves 🌊 as the 🥇FDA-approved treatment for MASH with fibrosis. Read Richie Manikat 's summary of this seminal NEJM trial ⏬ #livertwitter #GITwitter #MedEd #FOAMed aasld.org/liver-fellow-n…

Resmetirom (thyroid hormone receptor beta-selective agonist) has made 🌊 waves 🌊 as the 🥇FDA-approved treatment for MASH with fibrosis. 

Read <a href="/RichieManikat/">Richie Manikat</a> 's summary of this seminal <a href="/NEJM/">NEJM</a> trial ⏬ 

#livertwitter #GITwitter #MedEd #FOAMed 

aasld.org/liver-fellow-n…
Liver Fellow Network (@liverfellow) 's Twitter Profile Photo

Starting GI board study or wanting to brush up on your hepatology knowledge? We have just published another set of *excellent* practice questions! Enjoy!☺️ Jessica Davis #livertwitter #GITwitter #MedEd #FOAMed aasld.org/liver-fellow-n…

Starting GI board study or wanting to brush up on your hepatology knowledge? 

We have just published another set of *excellent* practice questions!

Enjoy!☺️ 

<a href="/DrJessicaDavis/">Jessica Davis</a> #livertwitter #GITwitter 
#MedEd #FOAMed

aasld.org/liver-fellow-n…
Jessica Davis (@drjessicadavis) 's Twitter Profile Photo

🚨🚨GI/hep fellows studying for boards!🚨🚨🚨 ⬇️76 hepatology practice questions now available thanks to AASLD & Liver Fellow Network aasld.org/liver-fellow-n… 👏 👏👏Major kudos to fellow authors & faculty editor Matt Odenwald! #livertwitter #gitwitter #meded

Daniel Huang (@drhuangdq) 's Twitter Profile Photo

Does liver stiffness progress faster in diabetes? Does HbA1c impact progression? Does LSM track changes in liver histology? Our prospective, multicentre study of biopsy-proven MASLD, out today HEPATOLOGY Journal MASLD Research Center Rohit Loomba AASLD journals.lww.com/hep/abstract/9…

Does liver stiffness progress faster in diabetes?

Does HbA1c impact progression?

Does LSM track changes in liver histology?

Our prospective, multicentre study of biopsy-proven MASLD, out today <a href="/HEP_Journal/">HEPATOLOGY Journal</a> 

<a href="/MASLDResearch/">MASLD Research Center</a> <a href="/DrLoomba/">Rohit Loomba</a> <a href="/AASLDtweets/">AASLD</a> 

journals.lww.com/hep/abstract/9…
Hanna Blaney, MD, MPH (@blaneymd) 's Twitter Profile Photo

📢 Stop giving patients with cirrhosis FFP to “correct” the INR! 🚫FFP To learn more on why, read Beverly Kyalwazi Liver Fellow Network post on coagulopathy of cirrhosis aasld.org/liver-fellow-n…

AASLD (@aasldtweets) 's Twitter Profile Photo

📞 Calling all trainees and fellows...are you ready to debate at #TLM24? 📹 Submit a two-minute video and application to be considered for the 2024 Academic Debate! Topic: #HCC Screening #LiverTwitter #GITwitter Liver Fellow Network bit.ly/4djkrBG

📞 Calling all trainees and fellows...are you ready to debate at #TLM24?    

📹 Submit a two-minute video and application to be considered for the 2024 Academic Debate! Topic: #HCC Screening #LiverTwitter #GITwitter <a href="/LiverFellow/">Liver Fellow Network</a> bit.ly/4djkrBG
UEGJ (@uegjournal) 's Twitter Profile Photo

🚨Assessment of #intestinal #inflammation via fecal #calprotectin💩 for early prediction of adverse outcomes in advanced #chronic #liver 🍑 #disease 📕only in UEGJ 🤗 tinyurl.com/yhc7cwhd Claudia Campani my_UEG #UEGJFridays #LiverTwitter #GITwitter #myUEGcommunity

🚨Assessment of #intestinal #inflammation via fecal #calprotectin💩 for early prediction of adverse outcomes in advanced #chronic #liver 🍑 #disease 

📕only in <a href="/UEGJournal/">UEGJ</a> 🤗
tinyurl.com/yhc7cwhd

<a href="/campani_claudia/">Claudia Campani</a>
<a href="/my_ueg/">my_UEG</a>

#UEGJFridays #LiverTwitter
#GITwitter #myUEGcommunity
Brian Horwich, MD, MS (@typical_brian) 's Twitter Profile Photo

Great learning about portomesenteric venous thrombosis (PMVT) writing this Why? Series post for Liver Fellow Network! Some Key Points: 🩸Cavernoma = chronic 🩸DOACs are safe and effective! 🩸Consider TIPS if associated sx or LT candidate aasld.org/liver-fellow-n… USC Division of GI & Liver

Great learning about portomesenteric venous thrombosis (PMVT) writing this Why? Series post for <a href="/LiverFellow/">Liver Fellow Network</a>!

Some Key Points:
🩸Cavernoma = chronic 
🩸DOACs are safe and effective! 
🩸Consider TIPS if associated sx or LT candidate 

aasld.org/liver-fellow-n…

<a href="/USC_KeckGILiver/">USC Division of GI & Liver</a>
AASLD (@aasldtweets) 's Twitter Profile Photo

📢 Liver Fellow Network Network, it's time to showcase your expertise at #TLM24. Less than 2️⃣ weeks left to submit your 📹 video and application to compete at the 2024 Academic Debate on #HCC Screening. #LiverTwitter #GITwitter bit.ly/4djkrBG

📢 <a href="/LiverFellow/">Liver Fellow Network</a> Network, it's time to showcase your expertise at #TLM24. 

Less than 2️⃣ weeks left to submit your 📹 video and application to compete at the 2024 Academic Debate on #HCC Screening. #LiverTwitter #GITwitter bit.ly/4djkrBG
Hepatology Communications (@hepcommjournal) 's Twitter Profile Photo

📑 Noninvasive predictors of clinically significant portal hypertension in #NASH cirrhosis❗️ 1️⃣ANTICIPATE (TE+Plt) & ANTICIPATE-NASH (+BMI) predict CSPH 2️⃣New model, ⭐️ FIB4+ (FIB4+Albumin), also predicts CSPH and does not require elastography❕ journals.lww.com/hepcomm/fullte…

📑 Noninvasive predictors of clinically significant portal hypertension in #NASH cirrhosis❗️

1️⃣ANTICIPATE (TE+Plt) &amp; ANTICIPATE-NASH (+BMI) predict CSPH

2️⃣New model, ⭐️ FIB4+ (FIB4+Albumin), also predicts CSPH and does not require elastography❕

journals.lww.com/hepcomm/fullte…
AASLD (@aasldtweets) 's Twitter Profile Photo

🌟 Hey, don’t miss your chance to take center stage at #TLM24! 🔜 TODAY is the final day to submit your application for the 2024 Academic Debate on #HCC Screening. #LiverTwitter #GITwitter bit.ly/4djkrBG

🌟 Hey, don’t miss your chance to take center stage at #TLM24! 

🔜 TODAY is the final day to submit your application for the 2024 Academic Debate on #HCC Screening. #LiverTwitter #GITwitter bit.ly/4djkrBG